Insider Trading

FATE Stock  USD 1.37  0.06  4.58%   
About 55% of Fate Therapeutics' investor base is interested to short. The analysis of the overall investor sentiment regarding Fate Therapeutics suggests that many traders are impartial. The current market sentiment, together with Fate Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Fate Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Fate Therapeutics Executive. Insider Public Trading

Read at macroaxis.com
Fate insider trading alert for general transaction of by Mozaffarian Neelufar, Executive, on 29th of July 2024. This event was filed by Fate Therapeutics with SEC on 2024-07-29. Initial filing of beneficial ownership - SEC Form 3

Cash Flow Correlation

Fate Therapeutics' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Fate Therapeutics' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Fate Therapeutics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Fate Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Fate Therapeutics Historical Investor Sentiment

Investor biases related to Fate Therapeutics' public news can be used to forecast risks associated with an investment in Fate. The trend in average sentiment can be used to explain how an investor holding Fate can time the market purely based on public headlines and social activities around Fate Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Fate Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Fate Therapeutics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Fate Therapeutics news discussions. The higher the estimate score, the more favorable the investor's outlook on Fate Therapeutics.

Fate Therapeutics Fundamental Analysis

We analyze Fate Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fate Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fate Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash Flow From Operations

Cash Flow From Operations Comparative Analysis

Fate Therapeutics is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.

Fate Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Fate Therapeutics stock to make a market-neutral strategy. Peer analysis of Fate Therapeutics could also be used in its relative valuation, which is a method of valuing Fate Therapeutics by comparing valuation metrics with similar companies.

Peers

Fate Therapeutics Related Equities

SANASana Biotechnology   7.38   
0%
100.0%
BEAMBeam Therapeutics   5.29   
0%
71.0%
ATRAAtara Biotherapeutics   4.94   
0%
66.0%
IPSCCentury Therapeutics   3.66   
0%
49.0%
PRMEPrime Medicine,   2.91   
0%
39.0%
RCUSArcus Biosciences   2.84   
0%
38.0%
EDITEditas Medicine   2.24   
0%
30.0%
CRSPCrispr Therapeutics   2.01   
0%
27.0%
RLAYRelay Therapeutics   1.34   
0%
18.0%
NTLAIntellia Therapeutics   1.10   
0%
14.0%
BPMCBlueprint Medicines   0.24   
3.0%
0%
CRBUCaribou Biosciences   2.24   
30.0%
0%
VERVVerve Therapeutics   3.77   
51.0%
0%

Complementary Tools for Fate Stock analysis

When running Fate Therapeutics' price analysis, check to measure Fate Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fate Therapeutics is operating at the current time. Most of Fate Therapeutics' value examination focuses on studying past and present price action to predict the probability of Fate Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fate Therapeutics' price. Additionally, you may evaluate how the addition of Fate Therapeutics to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Commodity Directory
Find actively traded commodities issued by global exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated